tradmap

VRDN Viridian Therapeutics, Inc.De

$22.95 +0.72%

Updated

Healthcare · Pharmaceutical Preparations

Viridian Therapeutics, Inc.De (VRDN) is a healthcare company in the Pharmaceutical Preparations industry, with a market capitalization of $2.6 billion. Shares last traded at $22.95, 34.4% below their 52-week high. Over the past year the stock is up 17.8%. Net profit margin is -544.1%, below the peer median of -8.9%. Revenue grew 23359.9% year over year.

Market Cap
$2.6B
Shares Out
113.3M
EPS (TTM)
$-9.56
P/E Ratio
P/S Ratio
36.56
P/B Ratio
3.93
Dividend / Share
Dividend Yield
52-Week High
$35.00
52-Week Low
$12.00
Volume
45,586
Avg Vol (3m)
111,250.889

Performance

1W
-5.73%
1M
+9.05%
3M
+38.58%
6M
-20.54%
YTD
-25.15%
1Y
+17.84%

Daily candles · volume · SMA(20)/SMA(50) · Databento EQUS.MINI.

Technicals

RSI (14)
53.62
SMA (50)
$21.02
SMA (200)
$23.82
Price vs SMA50
+9.22%
Price vs SMA200
-3.64%
ATR (14)
$1.52

Full technical analysis (26 indicators, D/W/M) →

Financials

Revenue
$71M
Net Income
$-387M
Gross Margin
Operating Margin
-569.7%
Net Margin
-544.1%
Return on Equity
-58.4%
Return on Assets
-35.3%
Current Ratio
16.95
Debt / Equity
0.03
Revenue Growth (YoY)
+23359.9%

Latest reported annual period ending 2026-06-30 · SEC EDGAR/XBRL.

Full financials — revenue, cash flow & debt over time →

Recent earnings

PeriodEPS (diluted)Reported
Q3 2024 $-2.98 2024-11-12
Q2 2024 $-1.82 2024-08-08
Q1 2024 $-0.79 2024-05-08
FY 2023 $-5.31 2024-02-27
Q3 2024 $-3.97 2024-11-12
Q2 2024 $-2.88 2024-08-08

Full earnings history →

Pharmaceutical Preparations peers

VRDN vs 14 industry peers (Pharmaceutical Preparations), by market cap. Updated

P/S vs peers
36.56 / 11.11 med
+229% premium
Net margin vs peers
-544.1% / -8.9% med
below median
1–14 of 14
LLYLilly (Eli)$1.09T40.8613.7033.5%-0.02%
JNJJohnson & Johnson$670.6B31.886.8521.5%+1.04%
ONCBeone Medicines Ltd.$535.9B817.2587.4310.7%+0.23%
ABBVAbbVie$459.8B72.877.149.8%-0.57%
MRKMerck$375.8B118.445.654.8%+0.44%
ABTAbbott Laboratories$189.5B30.204.2013.9%-1.50%
PFEPfizer$164.2B37.912.586.8%-0.76%
VRTXVertex Pharmaceuticals$141.5B32.1111.2435.0%+0.24%
BMYBristol Myers Squibb$139.1B14.982.8318.9%+0.62%
REGNRegeneron Pharmaceuticals$87.2B20.155.6127.9%-1.02%
TEVATeva Pharmaceutical Industries Ltd$42.6B60.412.464.1%-2.32%
ALNYAlnylam Pharmaceuticals$35.4B43.779.5221.8%-1.10%
ZTSZoetis$31.5B12.053.3127.5%+0.16%
RPRXRoyalty Pharma Plc$28.2B34.5611.1132.1%+1.24%

Source: SEC EDGAR (fundamentals/EPS/dividends) · Databento EQUS.MINI (prices) · market cap & yield computed by tradmap. Informational only — not financial advice.